Origin

China

Name of the vaccine

Generic name: Influenza A(H1N1) Vaccine (Split Virion), Inactivated

English name: Influenza A(H1N1) Vaccine (Split Virion), Inactivated

Pinyin name: Jiaxing H1N1 Liugan Bingdu Liejie Yimiao

Main composition and characters

Influenza A(H1N1)virus or like virus, recommended by WHO, approved by the Chinese SFDA, are cultured in healthy embryonated hen’s eggs, harvested, inactivated, concentrate and purified, then split and purified again, diluted with PBS as a buffer solution to formulate this vaccine. The vaccine is a slightly opalescent liquid with thiomersal as a preservative.

The influenza A (H1N1) virus antigen in each 0.5 ml equals to:

A/California/7/2009-like virus --------------------------15 µg Hemagglutinin

Object of inoculation

This vaccine is used in people who are susceptible to influenza A(H1N1), such as children, seniors, valetudinarian and people within an influenza epidemic area.

Function and purpose

This vaccine is used for the prophylaxis of influenza A(H1N1). It can raise anti-influenza A(H1N1) antibodies after inoculation.

Specifications

0.5ml/Vial. One dose is equal to 0.5ml，containing 15μg of influenza haemagglutinin of H1N1 virus strain.

Usage and Dosage

To inject in the deltoid of the upper arm by intramuscular injection (i.m.). 1 dose of 0.5 ml, is enough for adults and children of an age over 36 months.